Rizwan Ahmad
Last active: 4/12/2014

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis. Ahmad R, Chaturvedi R, Olivares-Villagómez D, Habib T, Asim M, Shivesh P, Polk DB, Wilson KT, Washington MK, Van Kaer L, Dhawan P, Singh AB (2014) Mucosal Immunol 7(6): 1340-53
    › Primary publication · 24670427 (PubMed) · PMC4221190 (PubMed Central)
  2. Claudin-1 regulates intestinal epithelial homeostasis through the modulation of Notch-signalling. Pope JL, Bhat AA, Sharma A, Ahmad R, Krishnan M, Washington MK, Beauchamp RD, Singh AB, Dhawan P (2014) Gut 63(4): 622-34
    › Citation · 23766441 (PubMed) · PMC4083824 (PubMed Central)
  3. Leukocyte superoxide dismutase activity in patients with chronic myeloid leukemia. Ahmad R, Singh R, Tripathi AK, Singh RK (2012) Rev Bras Hematol Hemoter 34(5): 394-5
    › Citation · 23125549 (PubMed) · PMC3486831 (PubMed Central)
  4. Oxidative stress and antioxidant status in patients with chronic myeloid leukemia. Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, Singh RK (2008) Indian J Clin Biochem 23(4): 328-33
    › Citation · 23105780 (PubMed) · PMC3453137 (PubMed Central)
  5. Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia. Tripathi P, Tripathi AK, Kumar A, Ahmad R, Balapure AK, Vishwakerma AL (2009) Indian J Hematol Blood Transfus 25(1): 10-6
    › Citation · 23100965 (PubMed) · PMC3453483 (PubMed Central)
  6. Cancer stem cells and colorectal cancer: an overview. Dhawan P, Ahmad R, Srivastava AS, Singh AB (2011) Curr Top Med Chem 11(13): 1592-8
    › Citation · 21446911 (PubMed)
  7. Studies on biomarkers for oxidative stress in patients with chronic myeloid leukemia. Singh RK, Tripathi AK, Tripathi P, Singh S, Singh R, Ahmad R (2009) Hematol Oncol Stem Cell Ther 2(1): 285-8
    › Citation · 20063559 (PubMed)
  8. S-phase fraction as a useful marker for prognosis and therapeutic response in patients with aplastic anemia. Tripathi AK, Tripathi P, Kumar A, Ahmad R, Singh RK, Balapure AK, Vishwakermad AL (2008) Hematol Oncol Stem Cell Ther 1(4): 216-20
    › Citation · 20058476 (PubMed)
  9. S-phase fraction as response marker in patients with chronic myeloid leukemia. Tripathi AK, Tripathi P, Ahmad R, Chaudhary PD, Verma SK (2009) Leuk Lymphoma 50(7): 1223-5
    › Citation · 19557645 (PubMed)
  10. DNA aneuploidy study for early detection of chromosomal abnormality in patients with aplastic anemia: prognostic and therapeutic implications. Tripathi P, Tripathi AK, Kumar A, Ahmad R, Balapure AK, Vishwakerma AL, Singh RK (2008) In Vivo 22(6): 837-44
    › Citation · 19181017 (PubMed)
  11. Malondialdehyde and protein carbonyl as biomarkers for oxidative stress and disease progression in patients with chronic myeloid leukemia. Ahmad R, Tripathi AK, Tripathi P, Singh S, Singh R, Singh RK (2008) In Vivo 22(4): 525-8
    › Citation · 18712183 (PubMed)
  12. Flow cytometric analysis of aneuploidy and S-phase fraction in chronic myeloid leukemia patients: role in early detection of accelerated phase. Tripathi AK, Chaturvedi R, Ahmad R, Asim M, Sawlani KK, Singh MK, Tripathi P, Tekwani BL (2003) Leuk Res 27(10): 899-902
    › Citation · 12860009 (PubMed)
  13. Peripheral blood leucocytes ornithine decarboxylase activity in chronic myeloid leukemia patients: prognostic and therapeutic implications. Tripathi AK, Chaturvedi R, Ahmad R, Asim M, Sawlani KK, Singh RL, Tekwani BL (2002) Leuk Res 26(4): 349-54
    › Citation · 11839377 (PubMed)